Assignee
ARCTURUS THERAPEUTICS INC
US·61 granted patents·36 pending applications·502 citations·filing 2012–2025
Top patents by PatentIndex Score
97 records- 0198US10526284B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Jan 7, 2020·16 cites·17 claims
- 0298US9670152B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Jun 6, 2017·52 cites·19 claims
- 0398US9593077B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2014·Granted Mar 14, 2017·88 cites·23 claims
- 0498US9580711B2Lipid particles with asymmetric cationic lipids for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Feb 28, 2017·20 cites·20 claims
- 0598US9567296B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2015·Granted Feb 14, 2017·77 cites·6 claims
- 0698US9365610B2Asymmetric ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2015·Granted Jun 14, 2016·30 cites·17 claims
- 0797US10487105B2Trinucleotide MRNA cap analogsARCTURUS THERAPEUTICS INC·Filed 2017·Granted Nov 26, 2019·19 cites·12 claims
- 0897US9896413B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·19 cites·20 claims
- 0996US10961188B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·7 cites·20 claims
- 1096US10781169B2Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 22, 2020·6 cites·20 claims
- 1196US10227302B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·12 cites·20 claims
- 1296US9850202B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Dec 26, 2017·15 cites·20 claims
- 1395US11744887B2Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·4 cites·28 claims
- 1495US10980895B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Apr 20, 2021·8 cites·20 claims
- 1595US10233148B2Aromatic ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·6 cites·20 claims
- 1695US9951002B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Apr 24, 2018·12 cites·20 claims
- 1794US12220455B2Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2023·Granted Feb 11, 2025·1 cites·33 claims
- 1894US10383952B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Aug 20, 2019·13 cites·16 claims
- 1994US9051570B2UNA oligomers for therapeuticsARCTURUS THERAPEUTICS INC·Filed 2012·Granted Jun 9, 2015·17 cites·9 claims
- 2093USRE49233EIonizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Oct 4, 2022·2 cites·25 claims
- 2193US10815463B2Messenger UNA molecules and uses thereofARCTURUS THERAPEUTICS INC·Filed 2017·Granted Oct 27, 2020·6 cites·19 claims
- 2293US9834510B2Aromatic ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2016·Granted Dec 5, 2017·4 cites·20 claims
- 2392US9856475B2Formulations for treating amyloidosisARCTURUS THERAPEUTICS INC·Filed 2015·Granted Jan 2, 2018·5 cites·18 claims
- 2492US9297009B2UNA oligomers targeting micro-RNA for therapeuticsARCTURUS THERAPEUTICS INC·Filed 2015·Granted Mar 29, 2016·8 cites·9 claims
- 2590US11685906B2Compositions and methods for treating ornithine transcarbamylase deficiencyARCTURUS THERAPEUTICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·25 claims
- 2690US9303260B2UNA duplex oligomers for therapeuticsARCTURUS THERAPEUTICS INC·Filed 2015·Granted Apr 5, 2016·6 cites·20 claims
- 2789US11015204B2Synthesis and structure of high potency RNA therapeuticsARCTURUS THERAPEUTICS INC·Filed 2018·Granted May 25, 2021·6 cites·28 claims
- 2889US2025161434A1Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2988US12390524B2Compositions and methods for inducing immune responsesARCTURUS THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·22 claims
- 3088US11938227B2Lipid nanoparticles encapsulation of large RNAARCTURUS THERAPEUTICS INC·Filed 2021·Granted Mar 26, 2024·2 cites·20 claims
- 3188US11759515B2Compositions and methods for inducing immune responsesARCTURUS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·1 cites·27 claims
- 3288US10369232B2Allele selective gene editing and uses thereofARCTURUS THERAPEUTICS INC·Filed 2016·Granted Aug 6, 2019·14 cites·25 claims
- 3388US9944929B2UNA single stranded oligomers for therapeuticsARCTURUS THERAPEUTICS INC·Filed 2016·Granted Apr 17, 2018·4 cites·9 claims
- 3488US2026069677A1Compositions and methods for inducing immune responsesARCTURUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3587USRE50681EIonizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2022·Granted Dec 2, 2025·0 cites·38 claims
- 3687US10457945B2UNA oligomers for therapeutics with prolonged stabilityARCTURUS THERAPEUTICS INC·Filed 2018·Granted Oct 29, 2019·3 cites·20 claims
- 3786US10421964B2UNA oligomers and compositions for treating amyloidosisARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·2 cites·16 claims
- 3886US10399937B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·2 cites·14 claims
- 3985US12070509B2Nucleic acids and methods of treatment for cystic fibrosisARCTURUS THERAPEUTICS INC·Filed 2021·Granted Aug 27, 2024·1 cites·34 claims
- 4085US9982259B2Transthyretin allele selective UNA oligomers for gene silencingARCTURUS THERAPEUTICS INC·Filed 2015·Granted May 29, 2018·5 cites·29 claims
- 4184US12398379B2Compositions and methods for treating ornithine transcarbamylase deficiencyARCTURUS THERAPEUTICS INC·Filed 2023·Granted Aug 26, 2025·0 cites·20 claims
- 4284US11737979B2Method of making lipid-encapsulated RNA nanoparticlesARCTURUS THERAPEUTICS INC·Filed 2020·Granted Aug 29, 2023·1 cites·19 claims
- 4384US2025304532A1Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4482US12290567B2Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugatesARCTURUS THERAPEUTICS INC·Filed 2020·Granted May 6, 2025·1 cites·19 claims
- 4580US12220485B2Method of making lipid-encapsulated RNA nanoparticlesARCTURUS THERAPEUTICS INC·Filed 2023·Granted Feb 11, 2025·0 cites·20 claims
- 4680US10556861B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Feb 11, 2020·1 cites·15 claims
- 4779US11407800B2Translatable molecules and synthesis thereofARCTURUS THERAPEUTICS INC·Filed 2018·Granted Aug 9, 2022·1 cites·19 claims
- 4879US2026078356A1Compositions and methods for treating ornithine transcarbamylase deficiencyARCTURUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4978US12286395B2Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2020·Granted Apr 29, 2025·0 cites·18 claims
- 5075US2025213495A1Method of lyophilizing lipid nanoparticlesARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 97 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ARCTURUS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →